Samantha Lo

Samantha Lo

Auto-generated profile, based on publicly available information

Samantha Lo

Celestialab Sdn Bhd, ALPS Global Holding, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WCWu Dong Cheng
Wu Dong Cheng
LBLuo Bin
Luo Bin
ZLZuo Xia Lin
Zuo Xia Lin
DYDing Yu
Ding Yu
DXDing Ke Xiang
Ding Ke Xiang
STSeng Kong Tham
Seng Kong Tham
Objective: Human umbilical cord mesenchymal stem cells (hUCMSCs) hold significant promise across various clinical applications. Therefore, regulatory requirements necessitate a thorough investigation of the hUCMSCs safety before clinical trials and potential allergic reactions after transplantation. Methods: Abnormal toxicity test employed mice and guinea pigs dosed daily at 0.5×106 cells and 5×106 cells, respectively for 7 days. Acute toxicity test employed low, medium, and high doses of hUCMSCs injected into mice once, followed by observations for 23 days. In systemic allergy test, guinea pigs received low and high dose of hUCMSCs, with sensitization and excitation stages at day 14 and 21, respectively. Results: The abnormal toxicity test of hUCMSC injections revealed no abnormal reactions over a seven-day observation period, indicating the safety of this administration route. In acute toxicity studies, the high-dose hUCMSCs group resulted in fatalities due to pulmonary embolism. Conversely, the low-dose group exhibited no toxic reactions or deaths. The maximum tolerated dose was determined to be >2×107 cells/kg. Systemic active allergy test showed that high doses of hUCMSC intravenous injections did not induce allergic reactions. Conclusion: This research affirms hUCMSC injections meet safety standards for clinical cell therapy, emphasizing their safe and promising clinical utility.

1 July 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SLSamantha Lo
Samantha Lo
EMEbrahim Mahmoudi
Ebrahim Mahmoudi
LHLooi Qi Hao
Looi Qi Hao
FNFatimah Mohd Nor
Fatimah Mohd Nor
Mh Busra FauziMh Busra Fauzi
Mh Busra Fauzi
Objective: Collagen, a widely used natural biomaterial polymer in skin tissue engineering, can be innovatively processed into nanocollagen through cryogenic milling to potentially enhance skin tissue healing. Although various methods for fabricating nanocollagen have been documented, there is no existing study on the fabrication of nanocollagen via cryogenic milling, specifically employing graphene oxide as separators to prevent agglomeration. Methods: In this study, three research groups were created using cryogenic milling: pure nanocollagen (Pure NC), nanocollagen with 0.005% graphene oxide (NC + 0.005% GO), and nanocollagen with 0.01% graphene oxide (NC+0.01% GO). Characterization analyses included transmission electron microscopy (TEM), scanning electron microscopy (SEM), Fourier transform infrared (FTIR) spectroscopy, x-ray diffraction (XRD), zeta potential (ZP), and polydispersity index (PDI). Results: TEM and SEM analysis revealed that nanocollagen groups alone exhibited particle sizes of less than 100 nm. FTIR spectroscopic investigations indicated the presence of amide A, B, and I, II, and III (1800 to 800 cm− 1) in all nanocollagen study groups, with the characteristic C-O-C stretching suggesting the incorporation of graphene oxide (GO). XRD data exhibited broadening of the major peak as the proportion of GO increased from pure NC to the nanocollagen groups with GO. Zeta potential measurements indicated electrostatic attraction of the samples to negatively charged surfaces, accompanied by sample instability. PDI results depicted size diameters ranging from 800 to 1800 nm, indicating strong polydispersity with multiple size populations. Conclusion: This research demonstrated that collagen can be successfully fabricated into nanoparticles with sizes smaller than 100 nm.

24 July 2023
Verified
Book Chapter
Closed access
SLSamantha Lo
Samantha Lo
WNWan Chiew Ng
Wan Chiew Ng
ebrahim mahmoudiebrahim mahmoudi
ebrahim mahmoudi
Mh Busra FauziMh Busra Fauzi
Mh Busra Fauzi
Nanotechnology is a greatly advancing field of scientific research due to its largely untapped potential, which may apply to various clinical uses. This book chapter focuses on the potential use of nanocollagen, graphene, and antibiotic components in biomaterial fabrication for wound healing. Nanocollagen is simply regular collagen broken down to the nanometer scale. Its nanocollagen-based biomaterials also conform to the ideals of tissue engineering, which are excellent biocompatibility with a high bioabsorption rate and little to no antigenicity while having an extensively cross-linked structure suitable for cellular growth and metabolism. Nanocollagen can be fabricated through electrospinning, nanolithography, self-assembly, and others. The physiology of wound healing follows specific proceedings, which are haemostasis, inflammation, and remodelling stages. The wound healing process may be improved through the use of nanocollagen biomaterials, together with the addition of graphene and antibiotics. Nanocollagen biomaterials aid in acting as a barrier for the wound against infections while providing collagen in the nanoscale to accelerate healing. The addition of antibiotics into the nanocollagen biomaterial aids in preventing bacterial infection by the inhibition of biofilm formation. Graphene, specifically in its oxide form, also acts as an antibacterial agent while potentially providing mechanical durability to the biomaterial scaffold. Along with the benefits of graphene oxide application in wound healing, its challenges are discussed in this book chapter. With that, this book chapter suggests the beneficial combinatorial factors of nanocollagen, graphene, and antibiotics that can potentially produce biomaterials with strong antibacterial properties while accelerating wound healing.